"Tory Sullivan MD provides top quality dermatological care in Fort Lauderdale, Miami Beach, and the surrounding communities. Sullivan Dermatology provides the latest and best in dermatologic science with a focus on compassionate treatment for all conditions of the hair, skin and nails. Our team of world-renowned experts in general, cosmetic and surgical dermatology is devoted to understanding every patient as an individual. A hands-on approach, clear communication, and the advancement of treatment through clinical research are the cornerstones of our practice."

During the past decade, Tory Sullivan, MD PA conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 8 clinical trials were completed, i.e. on average, 53.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 7 clinical trials were completed. i.e. 140% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Tory Sullivan, MD PA" #1 sponsor was "Actavis Inc." with 2 trials, followed by "Cassiopea SpA" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Aristea Therapeutics, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tory Sullivan, MD PA" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Tory Sullivan, MD PA" are "Acne Vulgaris" (3 trials), "Atopic Dermatitis" (3 trials), "Actinic Keratosis" (2 trials), "ACTINIC KERATOSIS" (1 trials) and "Acne Inversa" (1 trials). Many other conditions were trialed in "Tory Sullivan, MD PA" in a lesser frequency.

Most popular intervention types in "Tory Sullivan, MD PA" are "Drug" (15 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vehicle" (3 trials), "CB-03-01 cream, 1%" (2 trials), "Generic Ingenol Mebutate" (2 trials) and "Ingenol Mebutate (Picato®)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tory Sullivan, MD PA" are 16 trials for "All" genders.

Currently, there are NaN active trials in "Tory Sullivan, MD PA". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Tory Sullivan, MD PA, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tory Sullivan, MD PA, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".